|Articles|May 4, 2017
EMA Reviews Public Communication Strategy
Author(s)Philip Ward
The EMA has unveiled a new survey to assess how its communication strategy to the general public is perceived and valued by its stakeholders.
Advertisement
The European Medicines Agency (EMA) has unveiled a new survey to assess how its communication strategy to the general public is perceived and valued by its stakeholders.
The survey addresses how the agency communicates to the general public, and focuses on information made public mainly through the EMA website, including press releases and news announcements. EMA plans to distribute the results of the analysis.
“This will provide valuable feedback to help us to better plan and carry out our communication activities,” noted Monika Benstetter, Head of Media and Public Relations at EMA. “This is the second communications survey, the first having taken place in 2015, and it is anticipated that this exercise will be repeated every two years.”
The survey will be open until May 31, 2017, and Benstetter estimates that it should take you no longer than 10 minutes to complete. To access it, clickhere .
The survey addresses how the agency communicates to the general public, and focuses on information made public mainly through the EMA website, including press releases and news announcements. EMA plans to distribute the results of the analysis.
“This will provide valuable feedback to help us to better plan and carry out our communication activities,” noted Monika Benstetter, Head of Media and Public Relations at EMA. “This is the second communications survey, the first having taken place in 2015, and it is anticipated that this exercise will be repeated every two years.”
The survey will be open until May 31, 2017, and Benstetter estimates that it should take you no longer than 10 minutes to complete. To access it, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
September 12th 2025
- Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
Advertisement
Advertisement